Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

NCT03179787 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03179787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03179787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism
Lead sponsor
Otsuka Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
April 1, 2017
Completion date
July 6, 2020
Enrollment
528 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism